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Abstract
Pediatric neuroendovascular procedures are increasingly performed as several studies have shown the safety of these
interventions. In the literature, an upper limit of 4 French catheter size is conventionally used for femoral access in
neuroangiography of very young infants. However, this constraint in luminal size may not allow for more complex procedures. We present the previously unreported use of a radial 5 French slender catheter with ultrathin walls for femoral access
for aneurysm embolization in a 3-month-old boy presenting with left M2 aneurysm rupture.
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Background
Catheter-based neuroangiography and intervention in
the pediatric population poses challenges distinct from
the treatment of cerebrovascular disease in adults.1
Along with the unique cerebrovascular pathologies
found in children, the choice of endovascular techniques
is limited by the lack of devices developed speciﬁcally for
pediatric indications.2 Technical factors also increase the
diﬃculty for pediatric neurointerventional procedures,
particularly the smaller caliber of arteries for access.
Previous studies used an upper limit of 4 French catheter
size for femoral access in neuroangiography in very
young infants to prevent arterial morbidity.2–4
However, this restriction in inner diameter size may
not be suﬃcient in space for access to distal vasculature
and further intervention. Newer ‘‘slender’’ sheaths marketed for adult radial arterial access have ultrathin walls
allowing operators to achieve larger relative sheath inner
diameters while, crucially, preserving outer diameter. We
present the ﬁrst reported application of these radial
sheaths for femoral access in the very young pediatric
neurointerventional population.

Case presentation
A 3-month-old boy presented with one week of intermittent poor feeding, nonbilious vomiting and lethargy.

There was no documented fever or ill contacts.
Following one day of episodic focal facial seizures, he
was brought to the emergency department.
The patient was born at 39 weeks’ gestation via
spontaneous vaginal delivery with Apgar scores of 9
and 9 after an uncomplicated pregnancy. He met his
developmental milestones and did not have any signiﬁcant medical or surgical history. His family history was
unremarkable for aneurysms, vascular malformations
and seizures. Physical examination revealed an afebrile
infant with no dysmorphic features weighing 5605
grams. His anterior fontanelle was soft and neck was
supple. Neurologically he initially had a right-sided
facial droop, hypotonia in all extremities, with spasticity and hyperreﬂexia in the lower limbs. The patient
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was initially managed with a dose of lorazepam and a
loading dose of phenobarbital.
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microwire. Coil embolization was then performed
using both Stryker 360 Nano and Medtronic Axium
Prime coils for a total of ﬁve coils (Figure 2).

Investigations
Initial computed tomography (CT) demonstrated
a wedge-shaped hypodensity in the left hemisphere representing a left middle cerebral territory infarct with
associated hemorrhage in the left sylvian ﬁssure
(Figure 1(a)). Magnetic resonance imaging with
contrast redemonstrated the left middle cerebral
artery territory infarct with hemorrhagic conversion.
CT angiogram revealed a 7  6  3 mm lobulated fusiform left M2 aneurysm within the left sylvian ﬁssure
with surrounding hemorrhage (Figure 1(b) and (c)). No
other aneurysms were seen.
Following multidisciplinary case discussion, treatment of the aneurysm via an endovascular approach
was deemed safer than surgical bypass or microsurgical
clipping. Thus, endovascular embolization of the
aneurysm was oﬀered to the family. After a discussion
with the patient’s parents regarding the risks, beneﬁts
and alternatives of the procedure, verbal and written
informed consent was obtained.

Outcome and follow-up
Postprocedurally, the patient remained in the pediatric
critical care unit for hydration, initially requiring nasogastric supplementation because of decreased interest in
feeding. Over a few days he regained the ability to
breastfeed at baseline. He had slight residual facial
weakness with ﬂattening of the right nasolabial fold
but otherwise regained motor function, normal tone
and reﬂexes of the extremities. He did not develop
hypotension or vasospasm. He was discharged from
hospital two weeks after admission in stable condition
and was maintained on anticonvulsant therapy. At two
months’ follow-up in clinic, the patient had an unremarkable neurological exam, strong lower extremity
pulses and no femoral site complications. Magnetic resonance angiography at this time showed resolving
extraaxial hemorrhage, no interval ischemic infarction,
and no obvious ﬂow within the left middle cerebral
artery aneurysm (Figure 3).

Treatment

Discussion

The patient underwent technically successful cerebral
angiography and endovascular aneurysm embolization.
Under sterile technique, access to the left common femoral artery was obtained under ultrasound guidance
using a Cook micropuncture kit (Bloomington, IN,
USA) and a Terumo radial 5 French slender sheath
(Terumo, Japan). Thereafter, an SL-10 microcatheter
was navigated into the aneurysm over a Synchro

Pediatric neurointerventional procedures are increasingly performed, and multiple studies suggest low vascular morbidity and overall safety after diagnostic
neuroangiography5–7 and intervention.8 Creative yet
safe ‘‘borrowing’’ of adult neuroendovascular devices
is necessary as essentially no devices are marketed
speciﬁcally for children.2 Various authors report strategies to select catheter size relative to weight, namely

Figure 1. (a) Axial image from the initial unenhanced computed tomography (CT) scan demonstrates a wedge-shaped hypodensity in the
left middle cerebral territory representing an infarct, with associated hemorrhage in the left sylvian fissure. (b) Coronal image from the
maximum intensity projection of the CT angiogram demonstrates a 7  6  3 mm lobulated fusiform left M2 aneurysm. No other
aneurysms were seen. (c) Oblique image from the three-dimensional volumetric reconstruction of the CT angiogram of the left internal
carotid terminus demonstrates variant anatomy with an early bifurcation of the M1 segment. The fusiform aneurysm has an irregular
dome and arises at the origin of the angular M2 branch.
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Figure 2. (a) Cerebral angiogram with subselective injection in the left middle cerebral artery just prior to aneurysm embolization shows
the fusiform aneurysm arising at the origin of the left angular M2 branch. (b) Final angiography following primary coil embolization
demonstrates occlusion of the aneurysm with no residual flow, nontarget embolization or arterial extravasation.

Figure 3. (a) Axial image from the diffusion-weighted sequence of a magnetic resonance (MR) scan two months following primary coil
embolization shows no interval ischemic infarction. (b) Time-of-flight MR angiographic image shows no further aneurysmal filling.

a 4 French catheter size limit for children weighing less
than 7 kg in a study by Franken et al. and less than
10 kg in a more recent study by Gross and Orbach.
The former study showed that there is an increased
risk of vasospasm related to intervention within the
smaller vessels of younger children, which is a complication that can predispose to dissection and impeded
distal blood ﬂow.3 The latter study found an extremely
low incidence of femoral artery morbidity using their
rigid size parameters.2 A study by He and colleagues
suggested selecting catheter size based on age, speciﬁcally using a maximum catheter outer diameter of

4 French in any child under 5 years. This study found
that pediatric craniocervical arteries are smaller in
diameter than in adults until age 5, after which most
children’s arteries are approximately adult size.4 Thus,
there appears to be a convention of using a maximum
sheath size of 4 French for femoral access for neurointervention in very young children. However, this
restriction does not provide adequate luminal diameter
for more complex intervention.
In our embolization of a very young baby weighing
only 5.6 kg, we describe the repurposing of a newer
‘‘slender’’ radial 5 French sheath for femoral arterial
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access, which has not been previously reported in the
pediatric neurointerventional literature to the best of
our knowledge. These sheaths have an ultrathin wall
with an outer diameter equal to a standard femoral 4
French sheath while maintaining an inner diameter
equal to a standard femoral 5 French sheath.
Speciﬁcally, the outer diameter of a 5 French Terumo
Glidesheath SlenderÕ Introducer Sheath is 2.1 mm,
compared to an outer diameter of 2 mm for common
femoral 4 French catheters. However, the increased 5
French inner diameter of the Slender sheath allows for
a variety of neuroendovascular procedures in the very
young pediatric population that had not been previously possible. Recent case reports in the interventional
cardiology literature describe the successful use of
Glidesheath catheters for femoral access to reduce the
risk of femoral arterial occlusion in young children.9,10
In our case, there were no intraprocedural or postprocedure arterial complications.
The application of radial Slender sheaths may play a
potential role in pediatric neurointervention, for which
respect of diameter limitations is essential to prevent
arterial morbidity, while having an inner lumen spacious enough for complex intervention.
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